Bombardier Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Bombardier şirketinin toplam hissedar öz sermayesi $-2.1B ve toplam borcu $5.6B olup, bu da borç-öz sermaye oranını -258.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $12.6B ve $14.7B dir. Bombardier 'in FAVÖK'ü $827.0M faiz karşılama oranı 2 dur. Şirketin $1.0B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

-258.9%

Borç/özkaynak oranı

US$5.55b

Borç

Faiz karşılama oranı	2x
Nakit	US$1.02b
Eşitlik	-US$2.14b
Toplam yükümlülükler	US$14.75b
Toplam varlıklar	US$12.60b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Getting In Cheap On Bombardier Inc. (TSE:BBD.B) Might Be Difficult

Sep 06

Earnings Tell The Story For Bombardier Inc. (TSE:BBD.B) As Its Stock Soars 59%

May 23

Bombardier Inc.'s (TSE:BBD.B) CEO Will Probably Have Their Compensation Approved By Shareholders

Apr 19

Bombardier Inc. (TSE:BBD.B) Just Reported And Analysts Have Been Lifting Their Price Targets

Feb 12

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: BBD.B negatif hissedar özkaynağı var; bu, kısa vadeli varlıkların kısa vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Uzun Vadeli Yükümlülükler: BBD.B şirketinin negatif özkaynağı bulunmaktadır; bu, kısa vadeli varlıkların uzun vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: BBD.B negatif hissedar özkaynağı var ki bu yüksek borç seviyesinden daha ciddi bir durumdur.

Borcun Azaltılması: BBD.B 'in negatif özkaynağı var, dolayısıyla borcunun zaman içinde azalıp azalmadığını kontrol etmemize gerek yok.

Borç Kapsamı: BBD.B 'nin borcu işletme nakit akışı ( 9.8% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: BBD.B 'in borcuna ilişkin faiz ödemeleri EBIT ( 2 x kapsam) tarafından iyi karşılanmıyor.

Bombardier Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Getting In Cheap On Bombardier Inc. (TSE:BBD.B) Might Be Difficult

Executive VP & CFO exercised options and sold CA$374k worth of stock

Insider recently sold CA$2.0m worth of stock

Nextant Aerospac Now Offers Starlink Inflight Connectivity for Select Bombardier Business Aircraft

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Bombardier Announces Settlement of New York Bondholder Lawsuit

VP of Communications exercised options and sold CA$477k worth of stock

Bombardier Inc. to Report Q3, 2024 Results on Nov 07, 2024

Bombardier Inc. to Report Q2, 2024 Results on Jul 25, 2024

Bombardier Unveils Newly Branded Global 7500 and Challenger 3500 Aircraft at Catarina Aviation Show in Brazil, Kicking Off Demo Tour with World-renowned Jets

Insider exercised options to buy CA$4.2m worth of stock.

Insider recently sold CA$4.3m worth of stock

Bombardier Announces That It Intends to Vigorously Defend Itself After the Superior Court of Québec Authorized the Institution of A Previously Disclosed Securities Class Action for Persons Who Purchased Securities from August 2, 2018 to November 8, 2018

Earnings Tell The Story For Bombardier Inc. (TSE:BBD.B) As Its Stock Soars 59%

Investor sentiment improves as stock rises 20%

Insider exercised options and sold CA$748k worth of stock

Investor sentiment improves as stock rises 17%

Consensus EPS estimates increase by 15%

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Bombardier Inc.'s (TSE:BBD.B) CEO Will Probably Have Their Compensation Approved By Shareholders

Insider recently sold CA$767k worth of stock

Bombardier Inc. to Report Q1, 2024 Results on Apr 25, 2024

Bombardier Announces New Smart Services Offerings for Defense Customers with Predictable, Customizable Maintenance Options

New minor risk - Shareholder dilution

Bombardier's (TSE:BBD.B) Solid Profits Have Weak Fundamentals

Consensus EPS estimates fall by 18%, revenue upgraded

Bombardier Inc., Annual General Meeting, Apr 25, 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Bombardier Inc. Provides Earnings Guidance for the Year 2024

Is Bombardier Inc. (TSE:BBD.B) Trading At A 23% Discount?

Bombardier Inc. to Report Fiscal Year 2023 Results on Feb 08, 2024

Insufficient Growth At Bombardier Inc. (TSE:BBD.B) Hampers Share Price

New minor risk - Shareholder dilution

President exercised options and sold CA$2.5m worth of stock

Insider recently sold CA$1.8m worth of stock

Insider exercised options and sold CA$2.2m worth of stock

Investor sentiment improves as stock rises 15%

Consensus EPS estimates fall by 23%

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

New minor risk - Shareholder dilution

Bombardier Inc. Introduces Advanced Avionics Upgrade for In-Service Global Aircraft Equipped with the Bombardier Vision Flight Deck

President recently bought CA$519k worth of stock

Chairman of the Board of Directors exercised options and sold CA$274k worth of stock

Investor sentiment deteriorates as stock falls 19%

New major risk - Earnings quality

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Sentiment Still Eluding Bombardier Inc. (TSE:BBD.B)

Consensus EPS estimates fall by 10%

Bombardier's (TSE:BBD.B) Earnings Are Weaker Than They Seem

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Insider recently sold CA$772k worth of stock

Bombardier Inc. (TSE:BBD.B) Just Reported And Analysts Have Been Lifting Their Price Targets

Full year 2022 earnings released: US$1.66 loss per share (vs US$3.17 loss in FY 2021)

Bombardier Inc., Annual General Meeting, Apr 27, 2023

Bombardier Announces Executive Changes

Bombardier Inc. to Report Q3, 2023 Results on Nov 02, 2023

Bombardier Inc. to Report Q4, 2022 Results on Feb 09, 2023

Consensus forecasts updated

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin